Pegintron /01543001/


Combined with:

Rebetol
Ribavirin
Vx-950 (Telaprevir)

Indications and Reactions:

Role Indications Reactions
Secondary
Chronic Hepatitis C 62.1%
Hepatitis C 33.2%
Adverse Event 1.6%
Drug Use For Unknown Indication 0.8%
Prophylaxis 0.4%
Hypertension 0.4%
Hyperuricaemia 0.3%
Pain 0.2%
Convulsion 0.1%
Face Oedema 0.1%
Arthralgia 0.1%
Blood Pressure 0.1%
Gastrooesophageal Reflux Disease 0.1%
Headache 0.1%
Hypothyroidism 0.1%
Pyrexia 0.1%
Anaemia 0.0%
Anticoagulation Drug Level Therapeutic 0.0%
Cardiac Disorder 0.0%
Chronic Obstructive Pulmonary Disease 0.0%
White Blood Cell Count Decreased 28.0%
Neutrophil Count Decreased 16.6%
Retinopathy 8.1%
Renal Impairment 6.5%
Platelet Count Decreased 5.5%
Rash 5.3%
Vomiting 4.7%
Malaise 4.3%
Anaemia 2.6%
Renal Disorder 2.6%
Nausea 2.4%
Pyrexia 2.2%
Toxic Skin Eruption 2.0%
Haemoglobin Decreased 1.4%
Hyperuricaemia 1.4%
Presyncope 1.4%
Sepsis 1.4%
Weight Decreased 1.4%
Decreased Appetite 1.2%
Drug Eruption 1.2%
Concomitant
Hepatitis C 76.6%
Chronic Hepatitis C 6.8%
Product Used For Unknown Indication 5.3%
Ankylosing Spondylitis 1.4%
Hiv Infection 1.4%
Osteoporotic Fracture 1.4%
Prophylaxis 1.4%
Adverse Event 0.7%
Hepatic Cirrhosis 0.7%
Pain 0.7%
Anaemia 0.5%
Depression 0.5%
Gastritis 0.5%
Pain In Extremity 0.5%
Back Pain 0.2%
Diabetes Mellitus 0.2%
Factor Viii Deficiency 0.2%
Medical Diet 0.2%
Proctalgia 0.2%
Psoriatic Arthropathy 0.2%
Rash 13.8%
Agranulocytosis 9.2%
Drug Ineffective 8.0%
Nausea 6.9%
Haemoglobin Decreased 5.7%
Influenza Like Illness 5.7%
Colon Cancer 4.6%
Rash Generalised 4.6%
Renal Failure Acute 4.6%
Renal Impairment 4.6%
Vomiting 4.6%
White Blood Cell Count Decreased 4.6%
Fatigue 3.4%
Neutrophil Count Decreased 3.4%
Pyrexia 3.4%
Weight Decreased 3.4%
Depression 2.3%
Drug Eruption 2.3%
Drug-induced Liver Injury 2.3%
Erythema 2.3%

Drug Data